GR3017749T3 - Novel antibiotic compounds and their production. - Google Patents

Novel antibiotic compounds and their production.

Info

Publication number
GR3017749T3
GR3017749T3 GR950402849T GR950402849T GR3017749T3 GR 3017749 T3 GR3017749 T3 GR 3017749T3 GR 950402849 T GR950402849 T GR 950402849T GR 950402849 T GR950402849 T GR 950402849T GR 3017749 T3 GR3017749 T3 GR 3017749T3
Authority
GR
Greece
Prior art keywords
production
antibiotic compounds
novel antibiotic
novel
compounds
Prior art date
Application number
GR950402849T
Other languages
English (en)
Inventor
Herbert Dr Kogler
Hans-Wolf Dr Fehlhaber
Christopher Milton Dr Mathew
Dilip Jatashankar Upadhyay
Louis Ernest Linus Coutinho
Bimal Naresh Dr Ganguli
Juergen Dr Blumbach
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of GR3017749T3 publication Critical patent/GR3017749T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/07—Benzo[b]pyran-4-ones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/605—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin to a 1-benzopyran-2-on (or the chalcones and hydrogenated chalcones thereof, e.g. coumermycin, novobiocin, novenamin)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
GR950402849T 1991-02-26 1995-10-16 Novel antibiotic compounds and their production. GR3017749T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN57BO1991 IN172911B (el) 1991-02-26 1991-02-26
EP91107618 1991-05-10

Publications (1)

Publication Number Publication Date
GR3017749T3 true GR3017749T3 (en) 1996-01-31

Family

ID=33454354

Family Applications (1)

Application Number Title Priority Date Filing Date
GR950402849T GR3017749T3 (en) 1991-02-26 1995-10-16 Novel antibiotic compounds and their production.

Country Status (9)

Country Link
US (1) US5270182A (el)
EP (1) EP0512522B1 (el)
JP (1) JP3166126B2 (el)
AT (1) ATE127806T1 (el)
DE (1) DE69204733T2 (el)
DK (1) DK0512522T3 (el)
ES (1) ES2079724T3 (el)
GR (1) GR3017749T3 (el)
IN (1) IN172911B (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002027010A1 (fr) * 2000-09-29 2002-04-04 Taisho Pharmaceutical Co., Ltd. Compose a base de xanthone
KR100474653B1 (ko) * 2004-04-16 2005-03-14 동국제약 주식회사 타이코플라닌의 고순도 생산방법
US20050271755A1 (en) * 2004-05-12 2005-12-08 Ilya Raskin Phytomedicinal compositions for the control of lipid accumulation and metabolism in mammals
US20240158411A1 (en) * 2021-12-07 2024-05-16 Korea Institute Of Ocean Science & Technology Novel xanthone compound having excellent anticancer effect

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230692A (en) * 1978-11-03 1980-10-28 Ayerst Mckenna & Harrison, Inc. Ravidomycin and process of preparation
US4598145A (en) * 1982-08-16 1986-07-01 Bristol-Myers Company Albacarcins V and M
US4518589A (en) * 1983-10-03 1985-05-21 Bristol-Myers Company BBM-2478 Antibiotic complex
EP0219852B1 (en) * 1985-10-23 1992-02-05 Ishihara Sangyo Kaisha, Ltd. Chartreusin derivatives, salts thereof, antitumorous compositions containing the same, and processes for producing the same
JPS62207284A (ja) * 1986-03-07 1987-09-11 Rikagaku Kenkyusho 抗生物質ｒｋ−９５５ａ及びその製造法
EP0372986B1 (en) * 1988-12-09 1993-03-24 Kyowa Hakko Kogyo Kabushiki Kaisha Compound ks-505 and a process for producing the same

Also Published As

Publication number Publication date
EP0512522B1 (en) 1995-09-13
JP3166126B2 (ja) 2001-05-14
IN172911B (el) 1994-01-01
ATE127806T1 (de) 1995-09-15
US5270182A (en) 1993-12-14
DE69204733T2 (de) 1996-03-21
EP0512522A1 (en) 1992-11-11
DK0512522T3 (da) 1996-01-29
JPH05155888A (ja) 1993-06-22
DE69204733D1 (de) 1995-10-19
ES2079724T3 (es) 1996-01-16

Similar Documents

Publication Publication Date Title
EP0563345A4 (en) Novel 4-arylpiperazines and 4-arylpiperidines
TW234120B (el)
AU8771591A (en) Retroviral protease inhibiting compounds
TW207533B (el)
ZA93267B (en) Novel arylcyloakyl derivatives their production and their use
IE880125L (en) Naphthalene derivatives
JO1704B1 (en) New potent compounds
AU6307586A (en) Quinoline derivatives
IL118367A0 (en) Heteroaroyl derivatives
AP9400632A0 (en) Ether derivatives.
AP8800109A0 (en) "Heterocyclic insecticides".
GR3017749T3 (en) Novel antibiotic compounds and their production.
GR1002598B (el) Παραγωγα επι-επιβατιδινης.
CA2002597A1 (en) Solvates of b-lactam antibiotic
GR3004095T3 (el)
EP0377127A3 (de) Verwendung von Myricetin-3-0-beta-D-glucuronid als Arzneimittel
TW234715B (el)
JPS6434949A (en) Antibiotic fumifungine and manufacture
SU1823451A1 (ru) 2,3а-Дигидрокси-3-(4-толуоил)-3а,4-дигидро-1Н-пирроло[2,1-с][1, 4]бензоксазин-1,4-дион, проявляющий противомикробную активность в отношении кокковых форм бактерий
GB9118422D0 (en) Production of l-ascorbic acid-2-monophosphate
PH24971A (en) N2-thiocylcarbazate compounds and derivatives thereof
ES2099577T3 (es) Nuevas triazolopirimidonas, su obtencion y su empleo.